Aims: The objectives of this study were to replicate smoker profiles identified in Batra et al. (in press) and to develop a cluster-based classification system to categorize new cases into smoker profiles so that an appropriate tailored intervention could be applied.
Methods: Participants were smokers in southwest Germany who sought treatment for smoking cessation. In the first sample, discriminant analysis was used to create classification formulas for a future study (classification sample: n = 165). The second sample served to replicate the smoker profiles, which included participants reporting symptoms of hyperactivity/novelty-seeking, depressivity or high nicotine dependence as well as participants scoring low across smoking and psychological variables (replication sample: N = 134).
Results: Part 1 was focused on the development of formulas, using Fisher's coefficients, with which new cases could be classified. Part 2 adequately replicated previous findings concerning the smoker profiles, such that 70% of participants in the second sample were classified identically using cluster analysis and classification formulas.
Conclusions: The smoker profiles found in a previous study were replicated, and a classification system was developed for a future study which will test the efficacy of tailored treatments for the different smoker profiles.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6879078 | PMC |
http://dx.doi.org/10.1002/mpr.251 | DOI Listing |
Cytokine
January 2025
Centre for Medical Biotechnology, Maharshi Dayanand University, Rohtak, Haryana, India. Electronic address:
Background: Chronic smoking is an established risk factor for oral cancer (OC). The role of tobacco in oral squamous cell cancer (OSCC) emphasizes the need for non-invasive diagnostic approaches to identify early molecular alterations and improve patient outcomes. Salivary exosomes, which contain proteins, lipids, and nucleic acids, accessible and rich in biological content, making them interesting candidate biomarkers.
View Article and Find Full Text PDFJ Clin Pathol
January 2025
Department of Pathology and Laboratory Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA.
Br J Ophthalmol
January 2025
Department of Ophthalmology and Visual Sciences, Prince of Wales Hospital, Hong Kong, Hong Kong
Background: To report the presenting clinical, serological and treatment profiles of 1439 patients with thyroid eye disease (TED) from a tertiary centre in Hong Kong.
Study Populations: Consecutive patients with TED presented to the Thyroid Eye Clinic (TEC), the Chinese University of Hong Kong between 2014 and 2023.
Methods: Prospective cohort and masked review of medical records and orbital images.
J Clin Med
December 2024
Pharmacology, University of Padova, 35131 Padova, Italy.
Treatment of CV risk factors, such as cholesterol level, represents one of the main goals to reduce atherosclerotic burden. The aim of this study was to investigate the prescriptive appropriateness of cholesterol-lowering drugs among patients who experienced an atherosclerotic CV disease (ASCVD). : We investigated 155 patients who underwent cardiac rehabilitation in 2020.
View Article and Find Full Text PDFCancer Epidemiol
January 2025
Clinical Epidemiology Program, Instituto Nacional de Câncer (INCA), Rio de Janeiro, Brazil.
Introduction: Cancer has become a public health problem worldwide, affecting individuals of different age groups, including children, young adults and older patients.
Objective: To determine the clinical profile, staging and standard of oncological treatment of the 10 most frequent primary sites of cancer in young patients (< 60 years) vs older patients (≥ 60 years old) diagnosed between 2000 and 2019 in Brazil.
Materials And Methods: This cross-sectional study used data from the secondary database of the Hospital Cancer Registry, available on the web www.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!